Company Overview

HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

  • Name

    HCA Healthcare, Inc.

  • CEO

    Mr. Samuel N. Hazen

  • Website

    www.hcahealthcare.com

  • Sector

    Health Care Providers and Services

  • Year Founded

    1968

Profile

  • Market Cap

    $102.65B

  • EV

    $147.44B

  • Shares Out

    258.07M

  • Revenue

    $68.35B

  • Employees

    265,000

Margins

  • Gross

    40.27%

  • EBITDA

    19.54%

  • Operating

    14.9%

  • Pre-Tax

    12.38%

  • Net

    8.4%

  • FCF

    7.15%

Returns (5Yr Avg)

  • ROA

    10.22%

  • ROTA

    257.33%

  • ROE

    20.15%

  • ROCE

    21.86%

  • ROIC

    17.13%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $396.6

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $918M

  • Net Debt

    $41.86B

  • Debt/Equity

    31.94

  • EBIT/Interest

    5.11

Growth (CAGR)

  • Rev 3Yr

    6.86%

  • Rev 5Yr

    6.95%

  • Rev 10Yr

    6.81%

  • Dil EPS 3Yr

    13.48%

  • Dil EPS 5Yr

    15.45%

  • Dil EPS 10Yr

    19.69%

  • Rev Fwd 2Yr

    7.21%

  • EBITDA Fwd 2Yr

    7.63%

  • EPS Fwd 2Yr

    14.1%

  • EPS LT Growth Est

    12.51%

Dividends

  • Yield

  • Payout

    11.68%

  • DPS

    $2.52

  • DPS Growth 3Yr

    37.95%

  • DPS Growth 5Yr

    10.93%

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

    5.65%

NYSE:HCA